Olanzapine: Package Insert and Label Information (Page 8 of 8)

PRINCIPAL DISPLAY PANEL

Olanzapine Tablets USP  5mg  30s Label
(click image for full-size original)

Olanzapine Tablets USP 5mg 30s Label Text

NDC 54868-6365-0

OLANZAPINE
Tablets USP
5 mg

PHARMACIST: Dispense the accompanying
Medication Guide to each patient.

Rx only

30 TABLETS

PRINCIPAL DISPLAY PANEL

Olanzapine Tablets USP 7.5mg 30s Label
(click image for full-size original)

Olanzapine Tablets USP 7.5mg 30s Label Text

NDC 54868-6364-0

OLANZAPINE
Tablets USP
7.5 mg

PHARMACIST: Dispense the accompanying
Medication Guide to each patient.

Rx only

30 TABLETS

PRINCIPAL DISPLAY PANEL

Olanzapine Tablets USP 15mg 30s Label
(click image for full-size original)

Olanzapine Tablets USP 15mg 30s Label Text

NDC 54868-6358-0

OLANZAPINE
Tablets USP
15 mg

PHARMACIST: Dispense the accompanying
Medication Guide to each patient.

Rx only

30 TABLETS

OLANZAPINE olanzapine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54868-6358(NDC:0093-5771)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OLANZAPINE (OLANZAPINE) OLANZAPINE 15 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
CARRAGEENAN
CROSPOVIDONE
FD&C BLUE NO. 2
ALUMINUM OXIDE
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POLYETHYLENE GLYCOLS
Product Characteristics
Color BLUE Score no score
Shape OVAL (CAPSULE) Size 12mm
Flavor Imprint Code TEVA;5771
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54868-6358-0 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076000 07/02/2012
OLANZAPINE olanzapine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54868-6365(NDC:0093-5768)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OLANZAPINE (OLANZAPINE) OLANZAPINE 5 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
CARRAGEENAN
CROSPOVIDONE
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POLYETHYLENE GLYCOLS
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (Off-white) Score no score
Shape ROUND Size 8mm
Flavor Imprint Code TEVA;5768
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54868-6365-0 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076000 08/22/2012
OLANZAPINE olanzapine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54868-6364(NDC:0093-5769)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OLANZAPINE (OLANZAPINE) OLANZAPINE 7.5 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
CARRAGEENAN
CROSPOVIDONE
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POLYETHYLENE GLYCOLS
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (Off-white) Score no score
Shape ROUND Size 9mm
Flavor Imprint Code TEVA;5769
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54868-6364-0 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076000 08/22/2012
Labeler — Physicians Total Care, Inc. (194123980)
Establishment
Name Address ID/FEI Operations
Physicians Total Care, Inc. 194123980 relabel (54868-6358), relabel (54868-6364), relabel (54868-6365)

Revised: 08/2012 Physicians Total Care, Inc.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.